COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04439006
Recruitment Status : Not yet recruiting
First Posted : June 19, 2020
Last Update Posted : August 4, 2020
National Cancer Institute (NCI)
Janssen Scientific Affairs, LLC
Information provided by (Responsible Party):
Jennifer Woyach, Ohio State University Comprehensive Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : December 31, 2022